文献速递间质性肺疾病

STING相关婴儿期发病血管病(SAVI)成人发病一例报告

[STING-associated vasculopathy with onset in infancy: a case report].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2026-01-01

本文报道1例28岁男性成人发病的SAVI病例,表现为反复咳嗽、咳痰、喘息及四肢、胸背部红斑样皮疹,胸部CT示双肺多发细小网格影、不规则网状影,部分呈蜂窝影。追问家族史发现其母亲有间质性肺疾病病史,经临床全外显子基因检测发现STING1基因杂合突变c.842G>A(p.R281Q),明确诊断SAVI。患者随访1年,于2025年8月行肺移植手术,术后长期行预防排斥反应治疗,咳嗽、咳痰明显好转,仍有活动后气促,全身皮疹完全消退。

要点

  • 成人发病SAVI可表现为间质性肺病伴皮疹及全身炎症反应
  • 有间质性肺疾病家族史时应警惕基因遗传病并行基因检测
  • STING1基因c.842G>A(p.R281Q)杂合突变可确诊SAVI

核心结论

  • SAVI由编码STING的TMEM173基因突变导致,属自身炎症性疾病,典型发病于婴儿期,但也可成人发病。
  • 本例28岁男性经全外显子基因检测发现STING1基因c.842G>A(p.R281Q)杂合突变而确诊SAVI。
  • 患者行肺移植并长期预防排斥反应治疗后,咳嗽、咳痰明显好转,皮疹完全消退,但活动后气促仍持续。

研究设计与样本

  • 本文为个案报道,报告1例28岁男性成人发病的SAVI患者。

主要发现

  • 患者反复出现咳嗽、咳痰、喘息不适,伴四肢、胸背部红斑样皮疹。
  • 胸部CT提示双肺多发细小网格影、不规则网状影,部分呈蜂窝影。
  • 追问病史其母亲有间质性肺疾病病史,提示需警惕基因遗传病。
  • 全外显子基因检测发现STING1基因杂合突变c.842G>A(p.R281Q)。
  • 随访1年,患者于2025年8月行肺移植手术,之后长期行预防排斥反应治疗。

临床怎么用

  • 对间质性肺病伴皮疹及全身炎症反应者,尤其有间质性肺疾病家族史时,应警惕SAVI等遗传性疾病。
  • 疑诊时应行基因检测明确诊断,确诊后转诊至上级医院行专科管理。
  • 重症患者可考虑肺移植并长期预防排斥反应治疗。

局限性

  • 本文为单例个案报道,不能提供发生率、疗效比较等群体层面证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STING-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory disease caused by mutations in TMEM173 gene encoding STING (stimulator of interferon genes). It typically presents in infancy and is mainly characterized by interstitial lung disease, skin rash, and systemic inflammation. This report presents the case of adult-onset SAVI:A 28-year-old male patient was admitted with recurrent episode of cough, expectoration, chest tightness with shortness of breath and erythematous rashes on the extremities, chest, and back.His CT revealed bilateral diffuse fine reticular opacities and irregular reticular shadows, with focal areas of honeycombing. Further inquiry into the family history revealed that the patient's mother had been diagnosed with interstitial lung disease (ILD).Thus, a genetic etiology should be highly suspected.Later, whole-exome sequencing identified a heterozygous mutation in the STING1 gene: c.842G>A (p.R281Q), establishing the diagnosis of SAVI. The patient was subsequently referred to a tertiary care hospital for specialized management. During one year of follow-up, the patient underwent lung transplantation in August 2025 and had since received long-term immunosuppressive therapy for rejection prophylaxis. Cough and expectoration improved markedly, although exertional dyspnea persisted; the cutaneous rash had resolved completely. STING相关的婴儿期发病血管病(STING-associated vasculopathy with onset in infancy,SAVI)是由编码STING的TMEM173基因突变导致的一种自身炎症性疾病,发病年龄多在婴儿期,主要表现为间质性肺病、皮疹、全身炎症反应等。本文报道了1例成人期发病的SAVI患者:患者男,28岁,反复出现咳嗽、咳痰、喘息不适,伴四肢、胸背部红斑样皮疹,胸部CT提示双肺多发细小网格影、不规则网状影,部分呈蜂窝影。追问病史,其母亲有间质性肺疾病病史,故需警惕基因遗传病,经临床全外显子基因检测发现患者在STING1基因上有1个杂合突变:c.842G>A(p.R281Q),明确诊断SAVI。之后患者至上级医院就诊。对该患者已随访1年,其于2025年8月行肺移植手术,之后长期行预防排斥反应治疗,咳嗽、咳痰症状明显好转,但仍有活动后气促,全身皮疹已完全消退。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ye CZ, Wang HS, Han WY, et al. [STING-associated vasculopathy with onset in infancy: a case report]. Zhonghua Jie He He Hu Xi Za Zhi. 2026. PMID: 42373454. doi:10.3760/cma.j.cn112147-20260505-00254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。